Scinai Immunotherapeutics SCNI
NASDAQ SCNI
$0.29 +0.02 (+7.41%)
At close: Aug 20, 2026 · 4:00 PM EDT

Scinai Immunotherapeutics (SCNI) EPS (Diluted) (2017 - 2026)

Scinai Immunotherapeutics (SCNI) EPS (Diluted) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 12.23
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 7.33
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -1.96
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 2.05
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 1.19
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -0.06
8 Royalty Pharma 26.98 Bn 26.14 Bn - 0.15
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -0.72
10 Scinai Immunotherapeutics 1.08 Mn -3.11 Bn -1.12 Mn -1.06

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Mar 31, 2024 0.01
Dec 31, 2023 -0.04
Sep 30, 2023 0.00
Jun 30, 2023 0.01
Mar 31, 2023 0.02
Dec 31, 2022 -0.30
Sep 30, 2022 0.00
Jun 30, 2022 0.09
Mar 31, 2022 -0.03
Dec 31, 2021 0.08
Sep 30, 2021 -0.95
Jun 30, 2021 -1.01
Mar 31, 2021 -0.28
Dec 31, 2020 -3.45